Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Rosemary Cummins of NXT Financial and Ralph Highnam of Volpara Health Technologies.

A chance to meet with Mike, Horizon 3's Executive Chairman, and Matt, the Chief Investment Officer, as they talk about Horizon 3's origins, who its right for and what makes the fund distinctive.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Tony Locantro from Alto Capital and Sue MacLeman who serves in a number of roles with various organisations and companies. 

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &  Scott Power, Investment Committee at Horizon 3 Biotech.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital Markets Executive Dr Graeme Wald and Investment Analyst Scott Power who will be sharing topical investment strategies.

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. Matt & Scott Power, Investment Committee at Horizon 3 Biotech, discuss the origins of the Horizon 3 fund, what drives investment decisions and some of Scott's recommendations for investment in the coming months

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan Baldwin and Phamaxis CEO Gary Phillips.